Endobronchial Inflammatory Myofibroblastic Tumour-
A Case Report
Published: August 1, 2016 | DOI: https://doi.org/10.7860/JCDR/2016/20776.8270
Vishnukanth Govindaraj, Debasis Gochhait, Balla Nagamalli Kumar, Suryakala Narayanasami
1. Assistant Professor, Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), D Nagar, Puducherry, India.
2. Assistant Professor, Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), D nagar, Puducherry, India.
3. Junior Resident, Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), D Nagar, Puducherry, India.
4. Senior Resident, Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), D Nagar, Puducherry, India.
Correspondence
Dr. Vishnukanth Govindaraj,
No:3, Rajaya Street, Radhakrishnan Nagar, Ariyankuppam, Puducherry-605007, India.
E-mail: vishnu1429@yahoo.com
Lung malignancies are on the rise and sadly present at an advanced stage. Fiberoptic bronchoscopy is used for staging as well as in diagnosis of lung malignancies. However, not all endobronchial growth are malignant. Inflammatory Myofibroblastic Tumour (IMT) is one of the rare tumours of the lung. A controversy regarding the benign versus malignant nature of the tumour is still ongoing. The management of these tumours can be challenging because there are no established treatment protocols. Although IMT most commonly arises from lung, endobronchial presentation is very rare. We report a case of endobronchial presentation of IMT and discuss about its aetiology and treatment options.
[
FULL TEXT ] | [ PDF]